These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6817619)

  • 1. Studies on the effect of polyamines and their products on Ehrlich ascites tumours.
    Mondovì B; Gerosa P; Cavaliere R
    Agents Actions; 1982 Oct; 12(4):450-1. PubMed ID: 6817619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of irinotecan and flavonoids on Ehrlich ascites tumour-bearing mice.
    Knežević AH; Dikić D; Lisičić D; Kopjar N; Oršolić N; Karabeg S; Benković V
    Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):343-9. PubMed ID: 21624058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrocortisone protects cycloheximide-challenged mice pretreated with Ehrlich ascites tumour cells or with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1990 Oct; 103(3):315-9. PubMed ID: 2258469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamines and their biosynthetic enzymes in Ehrlich ascites-carcinoma cells. Modification of tumour polyamine pattern by diamines.
    Kallio A; Pösö H; Guha SK; Jänne J
    Biochem J; 1977 Jul; 166(1):89-94. PubMed ID: 901422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
    Hossain IA; Khanam JA; Jesmin M; Ali MM
    Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronucleated cells during the growth of the Ehrlich ascites tumour on spontaneous and by titanocenedichloride-induced conditions.
    Tarillion P; Taubert G; Nenning H
    Mutat Res; 1997 Mar; 389(2-3):213-8. PubMed ID: 9093386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal susceptibility to cycloheximide of mice bearing Ehrlich ascites tumours and of animals pretreated with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1988 Oct; 99(3):309-15. PubMed ID: 3204165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship.
    Llombart A; Mínguez FP
    Oncology; 1969; 23(3):201-8. PubMed ID: 5785067
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated polyamine levels in erythrocytes of SLC:ICR mice inoculated with Ehrlich ascites carcinoma cells.
    Uehara N; Shirakawa S; Uchino H; Saeki Y; Nozaki M
    Life Sci; 1980 Feb; 26(6):461-7. PubMed ID: 7374356
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinostatic effect of aliphatic aldehydes and aldehyde dehydrogenase activity in Ehrlich carcinoma, Sarcoma 180, and Yoshida AH 130 hepatoma.
    Perin A; Sessa A; Ciaranfi E
    Cancer Res; 1978 Jul; 38(7):2180-4. PubMed ID: 207425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
    Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
    J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of polyamines in evening primrose extract-induced apoptosis in Ehrlich ascites tumor cells.
    Arimura T; Kojima-Yuasa A; Tatsumi Y; Kennedy DO; Matsui-Yuasa I
    Amino Acids; 2005 Feb; 28(1):21-7. PubMed ID: 15700107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by derivatives of diguanidines of cell proliferation in Ehrlich ascites cells grown in cultures.
    Alhonen-Hongisto L; Pösö H; Jänne J
    Biochem J; 1980 May; 188(2):491-501. PubMed ID: 7396877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
    Ghosh P; Sur B; Bag SP; Sur P
    Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and cytotoxicity of novel nitroimidazole-polyamine conjugates in Ehrlich ascites tumour cells.
    Holley J; Mather A; Cullis P; Symons MR; Wardman P; Watt RA; Cohen GM
    Biochem Pharmacol; 1992 Feb; 43(4):763-9. PubMed ID: 1540230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of mouse interferons on the development of Ehrlich ascitic carcinoma].
    Solov'ev VD; Krispin TI; Balandin IG
    Biull Eksp Biol Med; 1980 Mar; 89(3):330-2. PubMed ID: 6155950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of glutathione in the antitumor effect of a copper-containing synthetic superoxide dismutase in mice.
    Oberley LW; Rogers KL; Schutt L; Oberley TD; Leuthauser SW; Sorenson JR
    J Natl Cancer Inst; 1983 Nov; 71(5):1089-94. PubMed ID: 6580486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.